COVID-19 Vaccine (Vero cell), Inactivated - World Health Organization
COVID-19 Vaccine (Vero cell), Inactivated
CoronaVac?
March, 2021
Platform description of vaccine
Copyright ? 2001-2020 Sinovac Biotech Ltd.
CONFIDENTIAL
CoronaVac? information
Copyright ? 2001-2020 Sinovac Biotech Ltd.
NAME Trade Name: CoronaVac? Name: COVID-19 Vaccine (Vero Cell), Inactivated
COMPOSITION
Active ingredient: Inactivated SARS-CoV-2 Virus (CZ02 s train) Adjuvant: Aluminum hydroxide Excipients: disodium hydrogen phosphate dodecahydra te, sodium dihydrogen phosphate monohydrate, sodium chloride
DESCRIPTION
CoronaVac? is a milky-white suspension. Stratified precipitate may form which can be dispersed by shaking.
TARGET GROUPS FOR VACCINATION
Susceptible people aged 18 and above.
PRESENTATION
Each vial (syringe) contains 0.5 mL with 600SU of inactivated SARS-CoV-2 virus as antigen. CONFIDENTIAL
CoronaVac? information
ADMINISTRATION AND SCHEDULE Two doses should be administered for primary immunization. The second dose is preferably given 1428 days after the first dose. CoronaVac should be administered by intramuscular injection in the deltoid region of the upper arm. It has not been determined whether this product requires booster immunization.
SHELF LIFE 24 months
PACKAGE
Vial or pre-filled syringe. One vial or syringe per box.
STORAGE
Store and transport between +2-8, and protect from light.
Copyright ? 2001-2020 Sinovac Biotech Ltd.
CONFIDENTIAL
Pre-clinical Study
Copyright ? 2001-2020 Sinovac Biotech Ltd.
CONFIDENTIAL
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- national adult immunization plan united states department of health
- percentage of eligible population who completed a primary vaccine
- grade table 1 what is the effectiveness of inactivated vero derived je
- acip etr framework janssen covid 19 vaccine february 28 2021
- covid vaccines approaches to vaccine trial design
- the value of vaccines in disease prevention a global perspective pfizer
- table 1 available vaccine efficacy data last updated august 9 2021
- understanding covid 19 vaccines valley med
- who unicef effective vaccine management evm
- potential public health impact of new tuberculosis vaccines
Related searches
- oxford covid 19 vaccine trial
- covid 19 vaccine updates
- covid 19 vaccine news
- covid 19 vaccine news today
- will covid 19 vaccine be mandated
- covid 19 vaccine update news
- covid 19 vaccine latest news progress
- covid 19 vaccine cambridge
- covid 19 vaccine refrigeration
- leading covid 19 vaccine candidates
- best covid 19 vaccine candidates
- the covid 19 vaccine development landscape